HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pier Capital, LLC 135,993$4,905,2680.70%
Verity Asset Management, Inc. 25,569$922,2740.68%
Must Asset Management Inc. 6,198$214,8840.59%
China Universal Asset Management Co., Ltd. 48,106$1,735,1830.54%
ArrowMark Colorado Holdings LLC 1,322,240$47,693,1970.52%
KENNEDY CAPITAL MANAGEMENT LLC 617,595$22,276,6520.52%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 368,584$13,294,8250.49%
WASHINGTON CAPITAL MANAGEMENT, INC 15,500$559,0850.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 349,900$12,620,8930.47%
Artisan Partners Limited Partnership 7,459,511$269,064,5620.43%
CLOUGH CAPITAL PARTNERS L P 118,600$4,277,9020.43%
Vivaldi Capital Management LP 35,078$1,265,2630.39%
Nebula Research & Development LLC 14,078$507,7930.38%
OAK RIDGE INVESTMENTS LLC 84,578$3,050,7280.38%
AFFINITY INVESTMENT ADVISORS, LLC 16,186$583,8290.34%
AMI ASSET MANAGEMENT CORP 151,746$5,473,4760.33%
HUSSMAN STRATEGIC ADVISORS, INC. 46,500$1,677,2550.31%
KORNITZER CAPITAL MANAGEMENT INC /KS 426,794$15,394,4600.30%
Linden Thomas Advisory Services, LLC 37,324$1,346,2880.30%
Birchview Capital, LP 10,000$360,7000.27%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.